TY - CHAP
T1 - Endovascular management of arteriovenous malformations
AU - Gross, Bradley A.
AU - Moon, Karam
AU - McDougall, Cameron
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Arteriovenous malformation (AVM) embolization can serve as a crucial adjunct before surgical resection, a partial approach to target high-risk features, or, rarely, as a curative approach for high-risk, surgically inaccessible lesions. Specifically, embolization is a welcome surgical adjunct to reduce the size of medium to large AVMs, to target perforator supply, and/or to target the deep portion of a nidus. In addition, a crucial role for embolization is the targeting of associated aneurysms, particularly in the setting of a ruptured lesion, regardless of the subsequent therapeutic modality. Rarely, a deep, small ruptured AVM that cannot be accessed surgically may be embolized with intent to cure. This chapter will review patient selection, technical nuances, and published results for AVM embolization. With appropriate patient selection and well-defined goals of embolization, the risk of procedural morbidity can be outweighed by its benefit.
AB - Arteriovenous malformation (AVM) embolization can serve as a crucial adjunct before surgical resection, a partial approach to target high-risk features, or, rarely, as a curative approach for high-risk, surgically inaccessible lesions. Specifically, embolization is a welcome surgical adjunct to reduce the size of medium to large AVMs, to target perforator supply, and/or to target the deep portion of a nidus. In addition, a crucial role for embolization is the targeting of associated aneurysms, particularly in the setting of a ruptured lesion, regardless of the subsequent therapeutic modality. Rarely, a deep, small ruptured AVM that cannot be accessed surgically may be embolized with intent to cure. This chapter will review patient selection, technical nuances, and published results for AVM embolization. With appropriate patient selection and well-defined goals of embolization, the risk of procedural morbidity can be outweighed by its benefit.
KW - arteriovenous malformation
KW - arteriovenous malformation embolization
KW - endovascular
KW - N-butyl cyanoacrylate
KW - Onyx
UR - http://www.scopus.com/inward/record.url?scp=85020089136&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020089136&partnerID=8YFLogxK
U2 - 10.1016/B978-0-444-63640-9.00006-0
DO - 10.1016/B978-0-444-63640-9.00006-0
M3 - Chapter
C2 - 28552159
AN - SCOPUS:85020089136
T3 - Handbook of Clinical Neurology
SP - 59
EP - 68
BT - Handbook of Clinical Neurology
PB - Elsevier B.V.
ER -